|
Simon Chin, MBA, President, CEO and Founder, has two decades of U.S. and international management experience in general administration, sales and marketing, technology development, and manufacturing within the biotechnology and semiconductor industries. He is the co-inventor of Iris’s patented predictive medicine platform. Prior to Iris, Mr. Chin was the CEO and Founder of DNA Laboratories where he developed key DNA chip technologies; he also held management positions at DuPont and other leading companies.
Mr. Chin has served on the board of directors of various organizations including BACUS/SPIE, the semiconductor photomask industry organization, the Saratoga Rotary Club, and the Metro YMCA of Santa Clara Valley ($40 million budget). He was also a Finance Commissioner in the City of Saratoga, and is an advisory board member of Santa Clara University’s Ignatian Center.
Mr. Chin has an MBA from Santa Clara University and a B.S. in Chemical Engineering from the University of California, Berkeley, where he was an Alumni Scholar. | 